Outcomes in patients diagnosed with early disease depend on a number of established prognostic and predictive factors such as hormone receptor status, human epidermal growth factor receptor 2 (HER2) status, tumor size, histologic grade, lymph node involvement, age, and molecular subtype [4]. The gene discussed is ERBB2; the disease is neoplasm.